2010 Doctors Physicians 
World of DTC Marketing
MARCH 23, 2022
85% of accelerated approvals from 2010 to 2020 were for oncology indications. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. of approvals), cancer (35.6%), and other rare diseases (24.7%). .” of approvals), cancer (35.6%), and other rare diseases (24.7%).
PM360
NOVEMBER 29, 2022
1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. Orchestrated omnichannel engagement has grown into a buzz phrase for commercial teams ever since they started using digital communications channels to engage with doctors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medico Reach
FEBRUARY 17, 2023
Understandably, almost 30% of Americans skipped all doctor visits last year, given the spiraling price of healthcare and the increasing complexity of our daily lives. Physicians and patients continue to have a very positive opinion of the organization. Doctor on Demand Headquarters: San Francisco, California Revenue: $75.9
Pharmaceutical Technology
MARCH 24, 2023
Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars. Further, there remains scepticism on the efficacy and safety of biosimilars.
Evolve Your Success
OCTOBER 18, 2022
There are two doctor offices in my hometown, which is extremely humbling because every time I walked in after I got abused by the front desk, they realized, “This is Omar Khateeb. The idea of trying to sell and influence hospitals and physicians using social media was a joke, but the data said otherwise. I burn the boats.
Pharma Marketing Network
OCTOBER 11, 2021
Patients and doctors went from trying to make sense of the platform to full-blown adoption where practices continue to incorporate it as an integral part of the go-to-market model. Telehealth has brought positive change for both patients and doctors. Digital Therapeutics have been around from as far back as 2010.
Pharma Marketing Network
OCTOBER 11, 2021
Patients and doctors went from trying to make sense of the platform to full-blown adoption where practices continue to incorporate it as an integral part of the go-to-market model. Telehealth has brought positive change for both patients and doctors. Digital Therapeutics have been around from as far back as 2010.
Expert insights. Personalized for you.
200 
Let's personalize your content